HYUGA PRIMARY CARELtd Valuation
Is 7133 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 7133 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 7133 (¥1295) is trading below our estimate of fair value (¥2417.77)
Significantly Below Fair Value: 7133 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 7133?
Key metric: As 7133 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 7133's PE Ratio? | |
|---|---|
| PE Ratio | 20.9x |
| Earnings | JP¥441.00m |
| Market Cap | JP¥8.95b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.3x |
| Enterprise Value/EBITDA | 12.1x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 7133's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 31.5x | ||
8769 Advantage Risk Management | 33.3x | n/a | JP¥11.2b |
7096 StemCell Institute | 38x | 42.1% | JP¥16.2b |
6059 UCHIYAMA HOLDINGSLtd | 18.8x | n/a | JP¥6.0b |
5127 GUPPY's | 36x | 33.0% | JP¥12.5b |
7133 HYUGA PRIMARY CARELtd | 20.9x | n/a | JP¥8.9b |
Price-To-Earnings vs Peers: 7133 is good value based on its Price-To-Earnings Ratio (20.9x) compared to the peer average (31.5x).
Price to Earnings Ratio vs Industry
How does 7133's PE Ratio compare vs other companies in the JP Healthcare Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 7133 is expensive based on its Price-To-Earnings Ratio (20.9x) compared to the JP Healthcare industry average (14.8x).
Price to Earnings Ratio vs Fair Ratio
What is 7133's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 20.9x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 7133's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
FINDEX
JP¥20.5b
Offers medical systems, office systems, and Healthtech products in Japan.
3649
JP¥800.00
7D
-0.5%
1Y
-15.3%
Suzuken
JP¥383.2b
Primarily engages in the distribution of pharmaceuticals in Japan and internationally.
9987
JP¥4,775.00
7D
0.2%
1Y
-4.4%
TOKAI
JP¥74.5b
Provides various healthy life services in Japan.
9729
JP¥2,213.00
7D
0.05%
1Y
18.2%